TREATMENT
Continuous glucose monitoring improved glucose control in adults but not in young adults or children with type 1 diabetes
| The first 150 words of the full text of this article appear below. |
R W Beck
Dr R W Beck, Jaeb Center for Health Research, Tampa, FL, USA; rbeck@jaeb.org
Does continuous glucose monitoring (CGM) improve glucose control in adults and children with type 1 diabetes?
Design: randomised controlled trial. ClinicalTrials.gov NCT00406133 [ClinicalTrials.gov] .
Allocation: {concealed}.*
Blinding: unblinded.
Follow-up period: 26 weeks.
Setting: 10 centres in the USA.
Patients:
322 adults and children
8 years of age who had type 1 diabetes for
1 year and glycated haemoglobin (HbA1c) concentrations of 7–10%, received intensive insulin therapy through an insulin pump or
3 daily injections, had not recently used CGM at home, and successfully completed a 1-week run-in phase. Patients were stratified into 3 age groups:
25 years (n = 98), 15–24 years (n = 110), and 8–14 years (n = 114).
Intervention:
CGM using a subcutaneous sensor (n = 165) or home monitoring using a blood glucose meter
4 times daily (n = 157).
Yale University School of Nursing, New Haven, Connecticut, USA
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
